Detalhe da pesquisa
1.
Exploring the value of apoB48 as a marker for atherosclerosis in clinical practice.
Eur J Clin Invest
; 42(7): 702-8, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22224712
2.
Triglyceride levels and apolipoprotein E polymorphism in patients with acute pancreatitis.
Hepatobiliary Pancreat Dis Int
; 11(1): 96-101, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22251476
3.
Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study.
BMC Med Genet
; 11: 66, 2010 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-20429872
4.
Omega 3 fatty acids induce a marked reduction of apolipoprotein B48 when added to fluvastatin in patients with type 2 diabetes and mixed hyperlipidemia: a preliminary report.
Cardiovasc Diabetol
; 8: 1, 2009 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-19133114
5.
Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitis.
BMC Gastroenterol
; 9: 46, 2009 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-19534808
6.
[Usefulness of the ankle-arm index for detection of peripheral arterial disease in a working population of Junta de Andalucía at Málaga]. / Rentabilidad del índice tobillo-brazo para la detección de enfermedad arterial periférica en población laboral de la Junta de Andalucía en Málaga.
Med Clin (Barc)
; 132(1): 7-11, 2009 Jan 17.
Artigo
em Espanhol
| MEDLINE | ID: mdl-19174058
7.
Management of dyslipidemia in the metabolic syndrome: recommendations of the Spanish HDL-Forum.
Am J Cardiovasc Drugs
; 7(1): 39-58, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17355165
8.
Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease. / Enfermedad del hígado graso no alcohólico, asociación con la enfermedad cardiovascular y tratamiento (II). Tratamiento de la enfermedad del hígado graso no alcohólico.
Clin Investig Arterioscler
; 29(4): 185-200, 2017.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-27692632
9.
Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (I). Nonalcoholic fatty liver disease and its association with cardiovascular disease. / Enfermedad del hígado graso no alcohólico, asociación con la enfermedad cardiovascular y tratamiento (I). Enfermedad del hígado graso no alcohólico y su asociación con la enfermedad cardiovascular.
Clin Investig Arterioscler
; 29(3): 141-148, 2017.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-27692633
10.
[The role of atherogenic dyslipidaemia in clinical practice guidelines]. / El papel de la dislipemia aterogénica en las guías de práctica clínica.
Clin Investig Arterioscler
; 28(2): 65-70, 2016.
Artigo
em Espanhol
| MEDLINE | ID: mdl-26949069
11.
Alzheimer's like brain changes correlate with low adiponectin plasma levels in type 2 diabetic patients.
J Diabetes Complications
; 30(2): 281-6, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26796431
12.
[Fibrates therapy: Rational use fenofibrate 2016. Executive summary]. / Terapia con fibratos: uso racional del fenofibrato 2016. Resumen ejecutivo.
Clin Investig Arterioscler
; 28(6): 295-301, 2016.
Artigo
em Espanhol
| MEDLINE | ID: mdl-27609708
13.
[The real measurement of non-HDL-cholesterol: Atherogenic cholesterol]. / La auténtica dimensión del colesterol-no-HDL: colesterol aterogénico.
Clin Investig Arterioscler
; 28(6): 265-270, 2016.
Artigo
em Espanhol
| MEDLINE | ID: mdl-27633523
14.
Significance of high density lipoprotein-cholesterol in cardiovascular risk prevention: recommendations of the HDL Forum.
Am J Cardiovasc Drugs
; 4(5): 299-314, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15449972
15.
[The combinations of statins and fibrates: pharmacokinetic and clinical implications]. / Combinaciones de estatinas y fibratos: implicaciones farmacocinéticas y clínicas.
Clin Investig Arterioscler
; 26 Suppl 1: 7-11, 2014 Jul.
Artigo
em Espanhol
| MEDLINE | ID: mdl-25043540
16.
[Glucagon-like peptide-1 (GLP-1) mimetics: a new treatment for Alzheimer's disease?]. / Análogos del glucagon-like peptide-1 (GLP-1): ¿una nueva estrategia de tratamiento para la enfermedad de Alzheimer?
Rev Neurol
; 59(11): 517-24, 2014 Dec 01.
Artigo
em Espanhol
| MEDLINE | ID: mdl-25418147
17.
Cognitive dysfunctions in middle-aged type 2 diabetic patients and neuroimaging correlations: a cross-sectional study.
J Alzheimers Dis
; 42(4): 1337-46, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25024335
18.
Use of expert consensus to improve atherogenic dyslipidemia management.
Rev Esp Cardiol (Engl Ed)
; 67(1): 36-44, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24774262
19.
Structural and functional brain changes in middle-aged type 2 diabetic patients: a cross-sectional study.
J Alzheimers Dis
; 40(2): 375-86, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24448784
20.
Incidence of cancer in a cohort of Spanish patients with systemic lupus erythematosus.
Reumatol Clin
; 9(6): 359-64, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24099959